MX2022010831A - Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas. - Google Patents

Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.

Info

Publication number
MX2022010831A
MX2022010831A MX2022010831A MX2022010831A MX2022010831A MX 2022010831 A MX2022010831 A MX 2022010831A MX 2022010831 A MX2022010831 A MX 2022010831A MX 2022010831 A MX2022010831 A MX 2022010831A MX 2022010831 A MX2022010831 A MX 2022010831A
Authority
MX
Mexico
Prior art keywords
extended release
injectable formulations
active agent
release injectable
methods
Prior art date
Application number
MX2022010831A
Other languages
English (en)
Inventor
Susan Mancini Cady
Peter Cheifetz
Izabela Galeska
Fallois Loic Le Hir De
Original Assignee
Boehringer Ingelheim Animal Health Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Animal Health Usa Inc filed Critical Boehringer Ingelheim Animal Health Usa Inc
Publication of MX2022010831A publication Critical patent/MX2022010831A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Formulaciones inyectables de liberación extendida para combatir parásitos en animales, que comprenden al menos un agente activo de isoxazolina, un polímero farmacéuticamente aceptable y un solvente. Esta invención también provee métodos mejorados para erradicar, controlar y prevenir infecciones e infestaciones por parásitos en un animal que comprende administrar las formulaciones inyectables de liberación extendida de la invención a un animal que lo necesita.
MX2022010831A 2015-04-08 2017-10-05 Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas. MX2022010831A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562144871P 2015-04-08 2015-04-08

Publications (1)

Publication Number Publication Date
MX2022010831A true MX2022010831A (es) 2022-09-29

Family

ID=57072717

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017012848A MX2017012848A (es) 2015-04-08 2016-04-06 Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
MX2022010831A MX2022010831A (es) 2015-04-08 2017-10-05 Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017012848A MX2017012848A (es) 2015-04-08 2016-04-06 Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.

Country Status (18)

Country Link
US (2) US20170020848A1 (es)
EP (1) EP3280413A1 (es)
JP (2) JP6824900B2 (es)
KR (1) KR102593069B1 (es)
CN (1) CN108055825B (es)
AR (1) AR104212A1 (es)
AU (3) AU2016246598B2 (es)
BR (1) BR112017021073A2 (es)
CA (1) CA2981797C (es)
CL (1) CL2017002536A1 (es)
CO (1) CO2017010065A2 (es)
EA (2) EA202090762A1 (es)
IL (1) IL254813B (es)
MX (2) MX2017012848A (es)
NZ (1) NZ736374A (es)
SG (2) SG11201708068PA (es)
UY (1) UY36610A (es)
WO (1) WO2016164487A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CN111032634A (zh) * 2017-04-05 2020-04-17 勃林格殷格翰动物保健美国公司 (s)-阿福拉纳的晶型
WO2018189314A1 (en) 2017-04-13 2018-10-18 Ceva Sante Animale Composition for treating worms infestations
AU2018363686B2 (en) 2017-11-07 2023-11-23 Intervet International B.V. Process for preparing large size isoxazoline particles
EP3707128B1 (en) 2017-11-07 2023-12-20 Intervet International B.V. Injectable isoxazoline pharmaceutical compositions and their use against parasite infestation
WO2019115492A1 (en) * 2017-12-12 2019-06-20 Intervet International B.V. Implantable isoxazoline pharmaceutical compositions and uses thereof
TWI812673B (zh) 2018-02-12 2023-08-21 美商富曼西公司 用於防治無脊椎害蟲之萘異噁唑啉化合物
PE20220173A1 (es) 2019-05-03 2022-01-28 Intervet Int Bv Composiciones farmaceuticas inyectables y usos de las mismas
FI4153133T3 (fi) * 2020-05-20 2024-01-30 Intervet Int Bv Injektoitavia farmaseuttisia koostumuksia ja niiden käyttöjä
CA3226162A1 (en) 2021-07-09 2023-01-12 Plexium, Inc. Aryl compounds and pharmaceutical compositions that modulate ikzf2

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
JPS4914624A (es) 1972-06-08 1974-02-08
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4203976A (en) 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
JPS57139012A (en) 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
EP0192060B1 (de) 1985-02-04 1991-09-18 Nihon Bayer Agrochem K.K. Heterocyclische Verbindungen
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
EP0246739B1 (en) 1986-03-25 1991-01-23 Sankyo Company Limited Macrolide compounds, their preparation and their use
DE3778768D1 (de) 1986-07-02 1992-06-11 Ciba Geigy Ag Pestizide.
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
EP0319142B1 (en) 1987-11-03 1994-04-06 Beecham Group Plc Intermediates for the preparation of anthelmintic macrolide antibiotics
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
NZ247278A (en) 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
US5330768A (en) 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5345377A (en) 1992-10-30 1994-09-06 Electric Power Research Institute, Inc. Harmonic controller for an active power line conditioner
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
US6733767B2 (en) * 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
WO2005085216A1 (ja) 2004-03-05 2005-09-15 Nissan Chemical Industries, Ltd. イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
JP5293921B2 (ja) 2005-09-02 2013-09-18 日産化学工業株式会社 イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
WO2007070606A2 (en) 2005-12-14 2007-06-21 E. I. Du Pont De Nemours And Company Isoxazolines for controlling invertebrate pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
KR20090005201A (ko) 2006-04-20 2009-01-12 이 아이 듀폰 디 네모아 앤드 캄파니 무척추 해충 방제용 피라졸린
JP2008044880A (ja) 2006-08-15 2008-02-28 Bayer Cropscience Ag 殺虫性イソオキサゾリン類
JP5256753B2 (ja) 2007-03-29 2013-08-07 住友化学株式会社 イソオキサゾリン化合物とその有害生物防除用途
NZ580241A (en) 2007-04-10 2011-02-25 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
MX2009013469A (es) 2007-06-13 2010-01-20 Du Pont Insecticidas de isoxazolina.
TWI430995B (zh) * 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
ES2399572T3 (es) 2007-10-03 2013-04-02 E. I. Du Pont De Nemours And Company Compuestos de naftaleno isoxazolina para el control de plagas de invertebrados
BRPI0915665B1 (pt) 2008-07-09 2018-01-02 Basf Se Misturas pesticidas, métodos para proteger plantas do ataque ou infestação por insetos, acarídeos ou nematódeos, para controlar insetos, aracnídeos ou nematódeos, uso de uma mistura, e, composição pesticida ou parasiticida
CA2747060A1 (en) * 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
PT2513104E (pt) * 2009-12-17 2016-06-03 Merial Inc Compostos de di-hidroazole antiparasitários e composições que compreendem os mesmos
MA34247B1 (fr) * 2010-05-27 2013-05-02 Du Pont Forme cristalline du 4-[5-[3-chloro-5-(trifluorométhyl) phényl] -4,5-dihydro-5-(trifluorométhyl)-3-isoxazolyl]-n-[2-oxo-2-[(2, 2,2-trifluoroéthyl) amino] éthyl]-1-naphtalènecarboxamide
DK178277B1 (da) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazolinforbindelser til bekæmpelse af fiskelus
KR101920476B1 (ko) 2010-12-27 2018-11-21 인터벳 인터내셔널 비.브이. 글리코푸롤을 포함하는 국소 적용 이속사졸린 제제
MX2013009211A (es) * 2011-02-10 2013-08-29 Novartis Ag Derivados de isoxazolina para controlar plagas de invertebrados.
BR112013023068B8 (pt) 2011-03-10 2022-11-22 Zoetis Llc Derivados de isoxazolina espirocíclica, seu uso e seu processo de preparação, e composições veterinárias
AR085657A1 (es) 2011-03-10 2013-10-16 Novartis Ag Compuestos de isoxazol
ES2715000T3 (es) * 2011-09-12 2019-05-31 Merial Inc Composiciones parasiticidas que comprenden un agente activo de isoxazolina, procedimientos y usos de las mismas
AR088669A1 (es) * 2011-11-21 2014-06-25 Lilly Co Eli Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
AR088668A1 (es) * 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
US8715711B2 (en) * 2011-12-02 2014-05-06 Merial Limited Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
PL2811998T3 (pl) 2012-02-06 2019-05-31 Merial Inc Pasożytobójcze doustne kompozycje weterynaryjne obejmujące ogólnoukładowo działające środki aktywne, sposoby oraz ich zastosowania
CA2882546A1 (en) 2012-09-07 2014-03-13 Zoetis Llc Spirocyclic isoxazolines as antiparasitic agents
EP2892347B1 (en) 2012-09-07 2019-08-14 Zoetis Services LLC Spirocyclic isoxazoline parasiticidal combinations
WO2014189837A1 (en) 2013-05-20 2014-11-27 Zoetis Llc Long-acting spiro-isoxazoline antiparasitic compositions
US10350196B2 (en) * 2013-09-30 2019-07-16 Zoetis Services Llc Long-acting spiro-isoxazoline formulations

Also Published As

Publication number Publication date
NZ736374A (en) 2024-02-23
AU2016246598B2 (en) 2020-07-23
JP2021050206A (ja) 2021-04-01
CN108055825A (zh) 2018-05-18
SG11201708068PA (en) 2017-10-30
CA2981797A1 (en) 2016-10-13
US20210299104A1 (en) 2021-09-30
JP6824900B2 (ja) 2021-02-03
BR112017021073A2 (pt) 2018-07-03
UY36610A (es) 2016-10-31
AR104212A1 (es) 2017-07-05
AU2016246598A1 (en) 2017-11-02
AU2020210266A1 (en) 2020-08-20
KR20170134700A (ko) 2017-12-06
CN108055825B (zh) 2021-03-30
AU2022202035A1 (en) 2022-04-14
CO2017010065A2 (es) 2018-01-05
IL254813A0 (en) 2017-12-31
CA2981797C (en) 2023-11-21
IL254813B (en) 2020-03-31
SG10201912724SA (en) 2020-02-27
EP3280413A1 (en) 2018-02-14
JP2018510897A (ja) 2018-04-19
KR102593069B1 (ko) 2023-10-23
US20170020848A1 (en) 2017-01-26
EA202090762A1 (ru) 2020-09-08
EA201792235A1 (ru) 2018-01-31
MX2017012848A (es) 2018-01-15
WO2016164487A1 (en) 2016-10-13
AU2020210266B2 (en) 2022-03-10
EA036272B1 (ru) 2020-10-21
CL2017002536A1 (es) 2018-04-20

Similar Documents

Publication Publication Date Title
MX2022010831A (es) Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
MX2020009010A (es) Formulaciones inyectables de larga duracion que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
NI201400842A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas.
MX2022003782A (es) Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de accion prolongada que los comprenden, metodos y usos de los mismos.
EA201400340A1 (ru) Пестицидные композиции, содержащие изоксазолиновый активный ингредиент, и способы их применения
MX2019012952A (es) Composiciones parasiticidas que comprenden derivados de indol, metodos y usos de los mismos.
CY1122755T1 (el) Eξισορροπημενες απο αποψη φυσιολογιας ενεσιμες μορφοποιησεις φωσνετουπιταντης
CL2016003271A1 (es) Métodos para tratar infecciones